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Available online 22 October 2018Background: Streptococcus pneumoniae is the leading cause of bacterial pneumonia worldwide. Previous reports
showed that IL-20 cytokines (IL-19, IL-20 and IL-24) are induced and have an immuno-regulatory function dur-
ing cutaneous infection. In the current study, our aim was to demonstrate the implication of IL-20 cytokines and
their receptors and their role during experimental pneumococcal infection.
Methods: C57BL/6 mice were infected with S. pneumoniae by intranasal route. The bacterial burden, the immune
response and the cytokine production were evaluated after treatment with an anti-IL-20 receptor-b (IL-20Rb)
neutralizing antibody (anti-IL-20Rb).
Findings: Of interest, expression of IL-20 cytokines mRNA and protein were transiently increased in the lung tis-
sue during infection. Blocking of the IL-20Rb decreased the bacterial burden both in the bronchoalveolar lavage
and the lung whereas there was no significant drop in the blood. This treatment also reduced the pulmonary
damages (as shown by the alveolar wall thickening), the recruitment of neutrophils and dendritic cells, and
the levels of the pro-inflammatory cytokines IL-1β and IL-6 in the lung. Administration of the anti-IL-20Rb anti-
body enhanced the synthesis of the antibacterial peptide LCN2. However, this effect is transient and did not affect
the survival of the infected mice.
Interpretation: Collectively, this study highlights the implication of IL-20 related cytokines during lung infection
by S. pneumoniae and might have therapeutic applications in bacterial pneumonia.
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Pneumococcal lung infections are a real public health problem and
are responsible for approximately 2 million deaths and cost hundred
billions of dollars per year [1]. Streptococcus pneumoniae (Sp) is a facul-
tative anaerobic Gram-positive diplococcus for which N90 serotypes
have been identified [2]. It is the most common cause of bacterial pneu-
monia and it is also implicated in sinusitis and bacterialmeningitis [3,4].
Sp colonizes the nasopharynx and can spread to the lower respiratory
tract via the airways [1].unity of Lille.
eur Calmette,
under the CC BY-NCThe severity of the pneumonia is tightly related to the efficiency of
the anti-bacterial host response. Both innate and adaptive immune re-
sponses participate in the clearance of the pneumococci [5]. Among
the factors orchestrating the anti-bacterial response, Th17-type cyto-
kines, including interleukin (IL)-17 and IL-22, play a major role in the
clearance of Sp [6–8] and the lung homeostasis by limiting injury and
maintaining tissue integrity, by modulating remodeling and the secre-
tion of antimicrobial peptides [6]. We also previously demonstrated
that the increased susceptibility to Sp inmice chronically exposed to cig-
arette smokewas due to a defective IL-22 response [9]. In this situation,
alteration of alveolar macrophages and dendritic cell (DC) function
leads to a lower secretion of these cytokines by conventional and non-
conventional T cells. IL-22 with IL-19, IL-20, IL-24 and IL-26 (IL-26
only present in humans), belong to the IL-20 cytokine subfamily, a sub-
set of the IL-10 family [10–12]. IL-19, IL-20 and IL-24 all bind the type I
IL-20 receptor (IL-20R), a heterodimeric receptor composed of the IL--ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before the study
Exposure to microorganismsmight be the cause of respiratory
infections which still are a major cause of death and an important
health problem. Among bacteria, Streptococcus pneumoniae was
recognized as a leading cause of pneumonia and hospital-
acquired opportunistic infections. The severity of the pneumonia
is tightly related to the efficiency of the defense mechanism.
Both innate and adaptive immune responses participate in the
clearance of the pneumococci. Among the factors orchestrating
the defense mechanism, IL-20 cytokines play a major role in the
clearance of the bacteria and the lung homeostasis by limiting in-
jury and maintaining tissue integrity. Whereas the role of inter-
leukin(IL)-22 is widely demonstrated, the implication of the
other IL-20 cytokines (IL-19, IL-20 and IL-24) acting through dif-
ferent pathways is unknown.
Added value of this study
We demonstrated that expression of IL-19, IL-20 and IL-24 were
transiently increased in the lung tissue with a peak at 24 h post-
infection. Blocking the binding of IL-20 cytokines to their receptor
improve the bacterial clearance and decrease the inflammatory re-
action and the tissue lesions during the first days of the infection.
Altogether, this study identified a new mechanism inhibiting the
lung defense mechanism against bacterial infection at the oppo-
site of IL-22.
Implications of all the available evidence
These data suggest that imbalance between IL-22 and the other
IL-20 cytokines might increase the susceptibility to respiratory in-
fection often observed during chronic inflammatory diseases.
Thus, targeting IL-20 cytokines might be valuable to improve the
control of respiratory bacterial infection.
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bind the type II IL-20R a heterodimeric receptor composed of the IL-22
receptorα1 subunit and IL-20Rb [13]. Thus, IL-20Rb subunit is the com-
mon chain to both receptor types recognizing IL-20 cytokines and
blocking antibodies against this receptor can efficiently neutralize this
pathway [14].
These IL-20Rb-containing receptor complexes are mainly expressed
on epithelial cells, mononuclear phagocytes and some lymphocytes. Re-
cent data also revealed that activated neutrophils expressed this recep-
tor [15]. Moreover, the role of IL-20 related cytokines is controversial
and exhibited some “anti-inflammatory” effects involved in the cutane-
ous tissue homeostasis [16]. However, Myles et al. have shown that IL-
20 related cytokines (IL-19, IL-20 and IL-24) promote cutaneous Staph-
ylococcus aureus infection in mice by downregulating IL-17 and IL-22
production [14]. However, their implication in lung bacterial infection
has not yet been evaluated.
In this study, our aim was to demonstrate the implication during
lung infection by SP and their role in this context. We hypothesized
that blocking the IL-20 pathway using an anti-IL-20Rb neutralizing an-
tibody could help to control such bacterial lung infection. For this, we
first analyzed the production of IL-20-related cytokines and their recep-
tors in lung tissues from mice infected by Sp. The impact of the treat-
ment with a blocking anti-IL-20Rb antibody was evaluated on the
bacterial clearance and lung inflammation as well as on the survival in
mice infected by Sp. This study identified IL-20 related cytokines andtheir receptor as modulators of the host response during Sp infection.
Thus, targeting IL-20Rb subunit might be valuable to improve the con-
trol of Sp infection.
2. Materials and methods
2.1. Animals
Six- to eight-week-oldmalewild-type C57BL/6 (H\\2Db)micewere
purchased from Janvier (SOPF animal facility, LeGenest-St.-Isle, France).
All animal work conformed to the guidelines of Animal Care and Use
Committee from Nord Pas-de-Calais (agreement no. AF 16/20,090).
Mice were maintained in a temperature-controlled (23 °C) facility
with a strict 12 h light/dark cycle with food and water provided ad
libitum.
2.2. Infection with streptococcus pneumoniae and bacterial counts
A clinical isolate S. pneumoniae serotype 1 (clinical isolate E1586)
was obtained from the National Reference Laboratory, Ministry of
Health, Uruguay and was grown as described previously [17]. For infec-
tion, frozen working stocks were diluted in phosphate- buffered saline
(PBS). The quantity of bacteria in the frozen stock was systematically
verified in each experiment and the quantity of bacteria was approxi-
mately the same before and after frozen. Anesthetized mice (intraperi-
toneal injection of ketamine (75 mg/Kg)-xylazine (5 mg/Kg) (50% of
each compound used in proportion) (Rompun 2% xylazine, Bayer and
Imalgene 1000, Merial) were intranasally infectedwith 2 × 106 bacteria
(in 50 μl). For the evaluation of the lung response to Sp, mice were
sacrificed by cervical dislocation at 12, 24 or 48 h post-infection. Bacte-
rial burden was measured by plating serial dilutions of lung extracts
(from the middle lobe grinded in 1 ml of PBS), bronchoalveolar lavage
(BAL) (pure, 1/10 to 1/1000) and blood (1/10 to 1/10000) samples
onto chocolate agar plates (Chocolate agar+ PolyViteX™, Biomérieux).
Colony-FormingUnits (CFU)were enumerated 24 h later and expressed
as CFU/ml. Survival experiments were also performed bymeasuring the
weight loss and the survival in infected mice during 6 days. In these ex-
periments, mice were sacrificed if we observed a weight loss higher
than 20% of the initial weight associated with behavior parameters
showing lethargy.
2.3. Treatment of mice with anti-IL-20Rb neutralizing antibody and Isotype
control
Treated animals received the endotoxin-free anti-IL-20Rb neutraliz-
ing antibody (clone 20RNTC, 50 μg/100 μl; eBioscience) by intraperito-
neal route, 24 h before and at day 1 and 3 after Sp infection. The 13R4
IgG2a- antibody was used as the isotype control (Evitria).
2.4. Broncho-alveolar lavage and tissue preparation
BAL was performed by washing the lungs five times with 0.5 ml of
phosphate-buffered saline solution (PBS) plus 2% fetal bovine serum
(FBS) (Gibco). After centrifugation at 400g for 6 min at 4 °C, the super-
natant (cell-free BAL fluid) was stored at −20 °C for cytokine analysis,
and the pellet was used for flow cytometry analysis.
The left lobe of the lung were mashed with a sterile blade then
digested with collagenase (Collagenase Type VI 17104–019 Gibco by
Life technologies) at 37 °C. After 15min of digestion, lungswere homog-
enized with an 18G needle and digested for 15min. After centrifugation
at 400g 6 min at 4 °C, the pellets were resuspended in a 30% Percoll so-
lution (Percoll TM GE Healthcare 17–0891-01) and centrifuged at 500g
for 15 min. The pellets were resuspended in red blood cells (RBC) lysis
buffer during 5 min at 20 °C, to remove erythrocytes. The reaction of
RBC lysis was stopped with PBS 2% FBS (Gibco). After centrifugation at
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then enumerated and used for flow cytometry.
2.5. Flow cytometer reagents
The cell phenotype on BAL and pulmonary cell suspension were an-
alyzed by flow cytometry using the following antibodies:
Monoclonal antibodies (mAbs) against mouse CD5 (ref130–102-
574, FITC-conjugated), Tetramer CD1d (NIH facility, PE-conjugated),
NK1.1 (ref 130–103-963, PerCp-Cy5.5–conjugated), CD4 (ref 130–102-
411, PE-Cy7- conjugated), CD25 (ref 130–102-550, APC-conjugated),
CD69 (ref 561,238, Alexa700-conjugated), TCRγδ (ref 130–104-016,
APC- Vio770 conjugated), TCR-β (ref 130–104-815, V450-conjugated),
CD8 (ref 130–109-252, V500-conjugated), CD45 (ref BLE103140,
BV605-conjugated) (BD Biosciences, Biolegend and Myltenyi Biotech),
I-Ab (ref 130–102-168, FITC- conjugated), F4/80 (ref 130–102-422, PE
conjugated), CD103 (ref 563,637, PerCP-Cy5.5-conjugated), CD11c (ref
558,079, PE Cy7-conjugated), CD86 (ref 560,581, Alexa-700 conju-
gated), Ly6G (ref 560,600, APC-H7 conjugated), CD11b (ref 560,455,
V45O conjugated), CD45 (ref 130–402-512, V500 conjugated), Ly6C
(ref BLE128036, BV605-conjugated) (BD Biosciences, Biolegend and
Myltenyi Biotech) and CCR2 (ref FAB 5538A, R&D systems, APC conju-
gated). Data were acquired on a LSR Fortessa (BD Biosciences) and ana-
lyzed with FlowJo™ software v7.6.5 (Stanford, CA, USA). Gating
strategies are described in supplementary Fig. 1 (See supplementary in-
formation). cDC1 were identified among DC, as CD103+ CD11b− cells
whereas cDC2 were CD11b+ CD103−.
2.6. Lung immunohistochemistry
For histopathology, the posterior lobe of lungs were fixed by infla-
tion and immersion in paraformaldehyde (PFA; 4%) and embedded in
paraffin. To evaluate airway inflammation, lung sections (4-μm thick)
were stained by hematoxylin & eosin. On these slides, we have mea-
sured both lung remodeling and inflammation through the use of lung
injury scoring as defined in the supplementary table 1 (See supplemen-
tary information).
For immunohistochemistry, paraffin-embedded lungs sections were
deparaffinized into two successive baths of xylene (Acros Organics)
during 10min and rehydratedwith successive baths of ethanol (succes-
sively, two baths of 100%, one bath of 90%, 80% and 50% during 5min for
all and one bath of water during 5 min). The unmasking of epitope was
carried out in pH 6.0 citrate buffer during 15 min at 90 °C. The kit
ab80436 – Expose Mouse and Rabbit Specific HRP/DAB Detection IHC
Kit (Abcam) was used according to the manufacturer's recommenda-
tion for detection of IL-19, IL-20 and IL-24. For IL-20 receptors, Fast
Red (SIGMAFAST™ Fast Red TR/Naphthol AS-MX Tablets) is used for
revelation. Counterstaining was performed with Hematoxylin
(Interchim).
We used as primary antibodies, an anti-IL-19 antibody [EPNCIR168]
ab154187 (Abcam); an anti-IL-20 antibody orb13501 (Biorbyt), anti-IL-
24 antibody orb228807 (Biorbyt), anti-IL-20Ra antibody bs-2619R
(Bioss), anti-IL-20Rb clone 20RNTC (eBiosciences) and an anti-IL-
22Ra1 clone 496,514 (R&D systems), all at 0.01 mg/ml.
In order to quantify the remodeling within the alveoli, we measured
the alveolar wall thickening in the peribronchial area by using the soft-
ware Image J (NIH). We analyzed at least 10 alveolar walls in the lungs
of 4 different mice for each group.
2.7. Cytokine measurement by individual ELISA system kit
IL-1β, IL-6, IL-19, and IFN-γ (eBiosciences), TNF-α (R&D (Abingdon,
UK), IL-20 (Boster Biological Technology) and IL-24 (Elabscience) were
determined in BAL and lung homogenates by enzyme-linkedimmunosorbent assay (ELISA), using commercial kits according to the
manufacturer's recommendations.
2.8. RNA isolation and quantitative RT-PCR
Total RNA was isolated from homogenized mouse lung (the cranial
lobe) using TRIzolR Reagent (Ambion) according to manufacturer's in-
structions and quantified by NanoVue Plus (Healthcare Bio-sciences
AB). Reverse transcription (RT) was performed with High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems) according to
manufacturer's instructions. cDNA were subjected to quantitative PCR
(QuantStudio 12 K Flex Applied Biosystems) using primers for mouse
reported in supplementary Table 2 (See supplementary information)
(Eurofins Genomics). Relative transcript expression of a gene is given
as−2ΔΔC using GAPDH as a housekeeping gene.
2.9. Statistical analyses
The experiments evaluating the response to Sp infection at 12, 24
and 72 h were repeated 3 times with 4–5 mice per group. In addition,
two experiments were performed with 10 mice per group for the sur-
vival analysis. Results are expressed as the mean ± SEM. Mann-
Whitney U analysis and non-parametric Kruskal-Wallis followed by
Dunns post tests were performed to determine significant differences
between groups using GraphPad Prism software version 5.00. Data are
expressed asmeans± SEM. Statistically significant differenceswere de-
fined as *P b .05, **P b .01 and ***P b .001.
3. Results
3.1. Infectionwith Sp initiates a pulmonary inflammatory reaction and trig-
gers septicemia
Mice were infected by intranasal administration of Sp (Fig. 1a).
Whereas the bacterial counts were unchanged in the BAL at 24 and
48 h post- infection (p.i), these numbers were strongly increased at
48 h in the lung tissue and the blood as compared to 24 h (Fig. 1b).
Moreover, total cell numbers were significantly increased in BAL and
lungs of infected mice at both time points in comparison to the baseline
which was control mice (PBS), associated with neutrophil recruitment
(Fig. 1c). The concentrations of IL-1β, IL-6 and IFN-γ were significantly
increased in the BAL of infected mice particularly at 24 h (Fig. 1d). In
thelung, the production of these cytokines as well as TNF-α continued
to increase until 48 h p.i (Fig. 1e). No significant change for these param-
eters was observed at 12 h p.i. (data not shown).
3.2. Infection with Sp triggers the lung expression of IL-20 cytokines and
their receptors
We next investigated the pulmonary amount of IL-20 related cyto-
kines during the course of Sp infection. Quantitative RT-PCR analysis in-
dicated enhanced expression of transcripts for Il-19, Il-20 and Il-24 as
well as for Il-22 at 24 h p.i, that decreased at 48 h p.i (Fig. 2a). No changes
were detected at 12 h p.i.
Immunohistochemistry staining revealed that IL-20 and IL-24 were
nearly undetectable at baseline (PBS condition),whereas airway epithe-
lial cells were strongly positive for IL-19. Infection with Spmarkedly in-
creased bronchial and peribronchial staining of these cytokines at 24 h
post-infection (see Table 1). In addition to bronchial epithelial cells,
pneumocytes aswell as inflammatory cells were positive for these cyto-
kines (Fig. 2b). No staining was reported with the isotype controls as
shown in the supplementary fig. 2 (See supplementary information).
Since IL-20 related cytokines were induced after Sp infection, we
then evaluated the expression of their receptors in the lung tissues of in-
fected mice. In contrast with Il-22ramRNA, expression of Il-20ra and Il-
Fig. 1. Infectionwith Streptococcus pneumoniae induces a pro-inflammatory response and bacterial dissemination in the blood. All datawere represented at 24 and 48h post-infectionwith
S. pneumoniae(Sp, 2.106 CFU). (a) Protocol of infection by Sp. (b) Bacterial load in BAL, lung tissues and blood as CFU counts per mL. (c) Total cell count in BAL and lung tissues (obtained
from themiddle right lobe), and neutrophils (PMN) number in lung tissue evaluated by flow cytometry. (d-e) IL-1β, IL-6, IFN-γ, and TNF-α levels in BAL (d) and lung lysates (the cranial
lobe) (e), evaluated by ELISA (pg/mL). Results were expressed as mean ± SEM and statistical analyses were performed byMann-Whitney U analysis and non-parametric Kruskal-Wallis
followed by Dunns posttest in comparison with PBS control. *Pb.05, **Pb.01 and ***Pb.001. Three independent experiments have been performed with 4-5 mice in each group.
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p.i., in comparison to PBSmice. Transcript levelswere similar to baseline
at 12 h and 48 h p.i (Fig. 3a). Immunohistochemical analysis revealedthe IL-20Rawas strongly expressed by airway epithelial cells at baseline
(PBS mice) whereas a light staining was detected for IL-20Rb and IL-
22Ra. Sp markedly increased bronchial and peribronchial staining of
Fig. 2. Streptococcus pneumoniae infection triggers IL-20 cytokine expression in the lung. Lungs from PBS group and frommice infectedwith S. pneumoniae(Sp, 2.106 CFU)were collected at
12, 24 and 48h p.i.. (a) Il-19, Il-20, Il-22 and Il-24mRNA levels were evaluated by RT-qPCR in lung tissue (the cranial lobe) of Spinfected mice and controls. Results were expressed as fold
increase compared to the mice exposed to PBS and using expression of Gapdh as a housekeeping gene. (b) Expression of IL-19, IL-20 and IL-24 was evaluated on lung sections by
immunohistochemistry (magnification x200) at 24h p.i. Lung sections were prepared from not infected mice (PBS), mice infected with Sp and infected with Sp and treated aby anti-IL-
20Rb antibody (Sp + anti-IL-20). Results were expressed as mean ± SEM and statistical analyses were performed by Mann-Whitney U analysis and non-parametric Kruskal-Wallis
followed by Dunns posttest in comparisonwith PBS controls, or with Sp at 48h p.i. *Pb.05 and **Pb.01. Three independent experiments have been performedwith 4-5mice in each group.
Table 1
Number of cells expressing IL-20 related cytokines and their receptors in peribronchial area from lung sections.
IL-19 IL-20 IL-24 IL-20Ra IL-20Rb IL-22Ra
PBS 24.8 ± 2.3 9.6 ± 1.6 13.9 ± 1.5 70.6 ± 5.2 33.2 ± 11.9 31.4 ± 4.8
Sp 84.4 ± 1.0 55.4 ± 5.9 64.5 ± 28.2 85.3 ± 2.3 51.9 ± 3.2 85.3 ± 2.3
Sp
+ anti-IL20Rb
62.9 ± 5.3 32.9 ± 5.5 56.5 ± 3.2 42.8 ± 9.8 25.3 ± 7.9 15.6 ± 2.1
Immunohistological staining of IL-20 related cytokines (IL-19, IL-20, and IL-24) and their receptors (IL-20Ra, IL-20Rb, IL-22Ra)were performed on lung tissues of PBS -, Sp – infectedmice
and Sp - infectedmice treatedwith the anti-IL-20Rbneutralizing antibody. Bronchial epithelial cellswere not included in the count sincemost of themare positive particularly for IL-19 and
IL-20Ra. The results are expressed as the mean number per mm2 of positive cells in 3 to 5 fields with standard deviation.
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Fig. 3. Expression of IL-20 receptors is amplified in lungs from mice infected with Streptococcus pneumoniae. Lungs from PBS group and from mice infected with S. pneumoniae (Sp,
2.106 CFU) were collected at 12, 24 and 48 h p.i.. (a) Il-20ra, Il-20rb and Il-22ramRNA levels in lung tissue of Sp infected mice were evaluated by RT-qPCR in lung tissue of Sp infected
mice and controls. Results were expressed as fold increase compared to the mice exposed to PBS and using expression of Gapdh as a housekeeping gene. (b) Expression of the IL-20Ra,
IL-20Rb and IL-22Ra was evaluated by immunohistochemistry (magnification x200) on lung sections collected at 24 h p.i. Lung sections were prepared from not infected mice (PBS),
mice infected with Sp (Sp) and infected with Sp and treated aby anti-IL-20Rb antibody (Sp + anti-IL-20). Results were expressed as mean ± SEM and statistical analyses were
performed by Mann-Whitney U analysis and non-parametric Kruskal-Wallis followed by Dunns posttest in comparison with PBS controls. *P b .05, and **P b .01. Three independent
experiments have been performed with 4–5 mice in each group.
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Table 1). Some binding was also detected within the inflammatory
cells in Sp mice. In contrast, the expression of IL-20Ra was
unchanged in the airway epithelial cells. Taken together, our data
reveals a basal expression for IL-19 and an enhanced expression of
IL-20 cytokines in the airways and in the inflammatory peribronchial
area early after infectionwith Sp. This is associated with an enhanced
expression of IL-20Rb and IL-22Ra mainly in airway epithelial cellswhereas IL-20Ra was strongly expressed at baseline and not modu-
lated by the infection.
3.3. Treatment with anti-IL-20Rb antibody decreases the bacterial load and
the inflammatory reaction
We next analyzed whether the neutralization of the IL-20Rb sub-
unit could affect the outcome of the pulmonary infection by Sp (Fig. 4a).
Fig. 4.Anti-IL-20Rb neutralizing antibody increases bacterial clearance in Streptococcus pneumoniae -infectedmice and limits the inflammatory reaction. (a) Protocol of infection by Sp and
treatment with anti-IL-20Rb neutralizing antibody or the isotype control. (b) CFU counts per mL in BAL, lung tissues (middle lobe) and blood 24 h p.i. (c) Total cell count in BAL and lung
tissues (left lobe). Results were expressed as mean ± SEM and statistical analyses were performed by Mann-Whitney U analysis and non-parametric Kruskal-Wallis followed by Dunns
posttest in comparison with PBS controls or with Sp+ IgG. *P b .05, **P b .01 and ***P b .001. Three independent experiments have been performed with 4–5 mice in each group.
423F. Madouri et al. / EBioMedicine 37 (2018) 417–427Blocking the IL-20Rb receptor significantly decreased the bacterial
burden in the BAL at 24 h p.i, and in the BAL and the lung 48 h p.i
(23% and 38% of inhibition respectively) (Fig. 4b). Treatment with
the anti-IL-20Rb antibody also decreased the number of total cells in
the BAL at 24 h, and in the lung tissues at 48 h (Fig. 4c), while there
was a trend to decrease the total cell number at the other time
point. This was confirmed by the analysis of lung sections. Indeed, his-
topathological scores exhibited a reduction of lung inflammation and
lesions 24 h p.i (anti-IL-20Rb treated Sp mice: 8.67 ± 1.58 vs IgG-
treated Sp mice: 13.3 ± 2.04) and 48 h p.i (anti-IL-20Rb treated Sp
mice: 9.5 ± 1.41 vs IgG-treated Sp mice: 13.83 ± 1.58) compared
with uninfected control mice (3.4 ± 0.68). We have also measured
the alveolar wall thickness in the three groups and our results showed
that Sp infection induced a significant thickening in alveolar walls as
reported in the supplementary fig. 3 (See supplementary informa-
tion). Moreover, treatment with the anti-IL-20Rb antibody completely
prevent the effect of the infection.
To determine which cell populations were impacted by the treat-
ment, we numbered the major subpopulations of inflammatory cells
by flow cytometry. Interestingly, our data revealed that the numbers
of neutrophils, and of cDC2 in the BAL were lower in mice treated
with anti-IL-20Rb than in infected controls while there was a trend to
decrease the number of alveolar macrophages (Fig. 5a). In the lung tis-
sues, treatmentwith the blocking anti-IL-20Rb antibodies decreased thenumber of neutrophils and of cDC2 (as well as the total number of DC)
at 48 h p.i (Fig. 5b).
Taken together, blocking the IL-20Rb pathway decreased the bacte-
rial load and the inflammatory cell recruitment (namely of neutrophils
and DC) after respiratory infection by Sp.
3.4. Anti-IL-20Rb antibodymodulates the production of inflammatory cyto-
kines and anti-microbial peptides
Since the blockade of the IL-20 pathway altered the inflammatory
cell recruitment after infectionwith Sp, the cytokine productionwas an-
alyzed in the BAL and the lung tissues (Fig. 6).
Treatment using anti-IL-20Rb antibody significantly decreased the
concentrations of IL-1β and IL-6 in the BAL collected at 24 h p.i. in in-
fected mice, in association with a trend for lower levels of IFN-γ
(Fig. 6a). In the lung tissues, the treatment with the anti-IL-20Rb anti-
body only reduced IL-1β (Fig. 6b). We also measured the levels of
Th17 cytokines in these samples and we did not observe any modula-
tion of the levels for IL-17 protein and IL-22 mRNA after blocking the
IL-20 pathway (supplementary Fig. 4 (See supplementary
information)).
We also checked the impact of the treatment with the anti-IL-20Rb
antibody on the expression of IL-20 cytokines themselves and on their
receptors. Compared to IgG-treated mice, administration of anti-IL-
Fig. 5. Anti IL-20Rb neutralizing antibody limits cell infiltration in BAL and lung of treatedmice. Natural Killer T (NKT) cells, polymorphonuclear neutrophils (PMN), alveolar macrophages
(AM), dendritic cells (DC), and resident DC (cDC1) and inflammatory DC (cDC2) were numbered by flow cytometry in the BAL (a) and the lung tissues (b) at 24 h p.i. Results were
expressed as mean ± SEM of absolute numbers calculated using the corresponding total cell counts. Results were expressed as mean ± SEM and statistical analyses were performed
by Mann-Whitney U analysis and non-parametric Kruskal-Wallis followed by Dunns posttest in comparison with PBS controls, or with Sp + IgG. *P b .05, **P b .01 and ***P b .001.
Three independent experiments have been performed with 4–5 mice in each group.
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without impacting IL-22 mRNA expression at 24 h p.i. (Fig. 7).
This treatment also affects the expression of IL-20Ra. This
was confirmed and extended by the immunohistochemistry
analysis. The administration of the anti-IL-20Rb antibody de-
creased the peribronchial and bronchial expression of IL-19, IL-20
and IL-24 (Fig. 2b), and. IL- 20Ra, IL-20Rb, and IL-22Ra (Fig. 3b).It also diminished the expression of IL-20Rb in airway epithelial
cells.
We also analyzed the expression of anti-microbial peptides involved
in the anti-infectious defense in the lung by RT-PCR. Sp infection ampli-
fied the expression ofDefb2 and Defb3mRNAat 24 h p.i. (Fig. 6c) but not
the expression of S100a8 and Lcn2 mRNA (Fig. 6d) as well as S100a9
mRNA (supplementary Fig. 5 (See supplementary information)).
Fig. 6. Anti-IL-20Rb neutralizing antibody modulates the production of pro- inflammatory cytokines and anti-microbial peptides. (a-b) IL-1β, IL-6, IFN-γ, and TNF-α levels evaluated by
ELISA (pg/mL) in BAL (a) and lung lysates (b) 24 h p.i. (c-d) mRNA level of the antimicrobial peptides β-defensins (Defb2 and Defb3) (c) and S100a8 and lipocalin-2 (lcn2) (d) were
evaluated by RT-qPCR in lung tissues (cranial lobe) at 24 h p.i. Results were expressed as fold increase compared to the mice exposed to PBS and using expression of GAPDH as a
housekeeping gene. Results were expressed as mean ± SEM. Results were expressed as mean ± SEM and statistical analyses were performed by Mann-Whitney U analysis and non-
parametric Kruskal-Wallis followed by Dunns posttest in comparison with PBS controls, or with Sp + IgG. *P b .05, **P b .01 and ***P b .001. Three independent experiments have been
performed with 4–5 mice in each group.
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mRNA expression while there was a trend for S100A8 and S100a9,
mainly 48 h p.i. This suggests that IL-20Rb blockade amplifies the ex-
pression some antimicrobial peptides which in turn, can facilitate the
bacterial clearance.
3.5. Anti-IL-20Rb antibody did not affect the weight loss and the survival in
mice infected by Sp
In order to determine the impact of the treatment with anti-IL-20Rb
antibody on the evolution of the infection in mice, we analyzed theweight loss and the survival during 6 days. Control mice lose N20% of
their weight at 4–5 days p.i. and the treatment with anti-IL-20Rb anti-
body did not affect this drop (supplementary Fig. 6 (See supplementary
information)). In parallel, some mice died at the same period and once
again, the treatment did not significantly modify their survival.
4. Discussion
It has been described previously that IL-20 related cytokines and
their receptors play a role in promoting S.aureus skin infections [14].
Moreover, it is known that IL-20 family cytokines are expressed in
Fig. 7. Anti IL-20Rb neutralizing antibody reduces the expression of IL-20 cytokines and their receptors in the lung of Streptococcus pneumoniae -infected mice. mRNA levels of the IL-20
related cytokines (IL-19, IL-20, IL-22, IL-24) and their receptors (IL-20Ra, IL-20Rb and IL-22Ra) in lung tissue ofmice infectedwith Sp evaluated by RT-qPCR. Results were expressed as fold
increase compared to themice exposed to PBS and using expression of GAPDHas a housekeeping gene. Results were expressed asmean± SEM and statistical analyseswere performed by
Mann-Whitney U analysis and non-parametric Kruskal-Wallis followed by Dunns posttest in comparison with PBS controls, or with Sp+ IgG. *P b .05, **P b .01 and ***P b .001. Three
independent experiments have been performed with 4–5 mice in each group.
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have demonstrated that infection by Sp promotes the production of
mostly IL-19 and IL-20, as well as the expression of IL-20Rb subunit of
the receptor.We also showed that the peak of IL-20 cytokine expression
was concomitantwith an effect of these cytokines on the bacterial clear-
ance and the inflammatory reaction, particularly by decreasing neutro-
phil and dendritic cell influx. Altogether, we have uncovered a critical
role for IL-20 receptors.
Sp colonizes the lower respiratory tract via its spreading through the
airways. Recognition of bacterial cell wall components of Sp
(lipoteichoic acids; LTA and peptidoglycan; PG) by Toll-like receptor 2
(TLR2) [19,20] induces the activation of the canonical nuclear factor
(NF)-ƙB pathway in antigen presenting cells [21]. The activation of
this pathway leads to the release of pro-inflammatory cytokines and
chemokines, such as IL-1β, IL-6 and TNF-α. Our data concerning the
evaluation of the inflammation and the cytokines in the BAL and lung
tissues of mice validated our experimental model with a production of
pro-inflammatory cytokines between 24 and 48 h p.i. We have shown
that IL-20 related cytokines (IL-19, IL-20, and IL-24 as well as IL-22)
are induced during this cytokine burst, at 24 h p.i both at the protein
and the mRNA levels. However, the mRNA expression of Il-19, Il-20, Il-
22, Il-24, Il-20ra, Il-20rb and Il-22ra mRNA nearly returns to baseline
levels at 48 h p.i. whereas these levels were not significantly different
to the PBS controls 12 h p.i As previously described for the majority of
NF-ƙb dependent cytokines in the lung, the protein expression for
these cytokines rapidly declines [8]. Recent data underlines that the
production of IL-20 cytokines is dependent on NF-ƙB [16] and could
be induced by TLR2 and TLR4 stimulation, both receptors being mobi-
lized by Sp [19,20]. At the mRNA level, the production of IL-19 and IL-
20 ismarkedly increased, despite no significant effect for IL-24. Interest-
ingly some recent data showed that this cytokine is induced by respira-
tory viruses suggesting that it could be more associated with viral
infection [22]. Interestingly, we detected a strong expression of IL-19
in the bronchial epithelium of control mice whereas we did not detect
a difference between the mRNA expression of Il-19, Il-20 and Il-24 in
the lung tissue as well as in bronchial epithelial cell cultures at baseline
(data not shown). This suggests that IL-19 is tightly post-transcriptionally regulated and that the protein might be stored within
the cytoplasm of these cells. After Sp challenge, we detected an in-
creased expression in airway epithelial cells (within the bronchi and
the alveoli) as well as in the inflammatory infiltrate. DC and macro-
phages are able to produce these cytokines and we observed that
monocyte-derived DC secretes these cytokines after activation by Sp
(manuscript in preparation). Of note, using multiple Sp inocula in our
experiments instead of a lethal dose of Sp could have also been informa-
tive to better decipher the role of IL-20 cytokines.
It has been shown in a model of cutaneous infection, that IL-20 fam-
ily cytokines are initially secreted by infiltrating innate immune cells
and lymphocytes 24 h after challenge [14]. Most research has been fo-
cused on IL-22, but we know that during inflammation, IL-19, IL-20
and IL-24, binding to their receptors, induce cell recruitment (neutro-
phils, dendritic cells and T cells), antimicrobial peptides expression (β-
defensin or S100A peptides) as well as chemokines and cytokines pro-
duction [16]. Among the cytokines produced, the binding of IL-20 re-
lated cytokines to their receptors allow a positive autocrine loop
expression of IL-19, IL-20 and IL-24, which amplify their effect during
inflammation [16,23]. Our data showing that neutralization of IL-20Rb
subunit decreases the expression of IL-20 family cytokines (IL-19, IL-
20 and IL-24) and their receptors could potentially be explained by an
autocrine loop. Interestingly, the inflammatory cell recruitment (specif-
ically, neutrophils andDC aswell as AM in the BAL) due to Sp infection is
reduced after blocking the IL-20 pathway suggesting that this process
might also participate in the lower level IL-20 cytokine expression.
Moreover, this decreased recruitment was associated with a lower pro-
duction of pro-inflammatory cytokines like IL-1β, IL- 6 and IFN-γ. In-
deed, inflammatory cells are potential sources for these cytokines.
Myles et al. reported that IL-20 related cytokines promote cutaneous
Staphylococcus aureus infection in mice by downregulating the Th17
cytokines-dependent pathway [14]. Sincewe are unable to detect an in-
creased production of IL-17/IL-22 and pro-Th17 cytokines (such as IL-
1β and IL-6) in lung tissues of Spmice treatedwith anti-IL-20Rbneutral-
izing antibody, we speculate that IL-20 family cytokines boost the anti-
bacterial activity of these effector cells as shown in vitro in neutrophils
[15]. Indeed, blocking IL-20Rb pathway promotes bacterial clearance
427F. Madouri et al. / EBioMedicine 37 (2018) 417–427in BAL and lung of treatedmice, although it decreases the influx of neu-
trophils andmacrophages. Additional experiments are required to ana-
lyze the effector functionwithin these cells in infectedmice treatedwith
the anti-IL-20Rb blocking antibody. The treatment with the anti-IL-
20Rb antibody also amplifies the mRNA expression of selected antimi-
crobial peptides including Lcn2 while there was a trend for S100a8
mRNA. Administration of the anti-IL-20Rb antibody did not modulate
the β-defensin mRNA expression (Defb2, Defb3) which are usually pro-
duced by pulmonary epithelial cells and neutrophils during Sp infection
[24]. Interestingly, it has been shown that S100 anti-microbial peptides
(expressed by neutrophils, monocytes and activated endothelial and
epithelial cells) control bacterial clearance by inducing lung recruitment
of neutrophils and macrophages during Sp infection [25,26]. Lcn2-
deficient animals also exhibit higher susceptibility to infection com-
pared to control animals [27].
The understanding of the mechanisms underlying the beneficial ef-
fects of the treatment using anti-IL-20Rb antibody is ongoing and will
be helpful to limit pulmonary bacterial infections. Interestingly, this ef-
fect is associated with a lower histopathological score measuring both
the inflammation and the airway remodeling as illustrated in the
Figs. 2b and 3b, a result confirmed at the level of neutrophils, dendritic
cells and macrophages by flow cytometry analysis. However, this effect
was not associated with a significant impact on mice survival and loss
weight which is prominent after day 3 p.i. This is probably related to
the drop in the production of IL-20 cytokines observed at day 2 p.i. in
our acute model of infection. These data suggest that it is necessary to
associate this treatment with another therapeutic approach such as an-
tibiotic, in order to improve the efficiency of the anti-IL-20Rb blocking
antibody.
In conclusion, we show that IL-20 related cytokines and their recep-
tors are induced during Sp lung infection and that the treatment using
an anti-IL-20Rb neutralizing antibody limits inflammation due to Sp.
Moreover, combined treatment of lung infection associating a molecule
blocking the IL-20 pathwaywith antibioticsmight be helpful to acceler-
ate bacterial clearance and to prevent the tissue lesions associated with
uncontrolled inflammation.
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